Management of non-ST-elevation acute coronary syndromes: how cost-effective are glycoprotein IIb/IIIA antagonists in the UK National Health Service? (Q56458776)

From Wikidata
Jump to navigation Jump to search
article
edit
Language Label Description Also known as
English
Management of non-ST-elevation acute coronary syndromes: how cost-effective are glycoprotein IIb/IIIA antagonists in the UK National Health Service?
article

    Statements

    Management of non-ST-elevation acute coronary syndromes: how cost-effective are glycoprotein IIb/IIIA antagonists in the UK National Health Service? (English)
    0 references
    0 references
    0 references
    0 references
    0 references
    Stephen Palmer
    0 references
    Zoe Philips
    0 references
    Mike Robinson
    0 references
    Laura Ginnelly
    0 references
    Ameet Bakhai
    0 references
    Nicola Cooper
    0 references
    Chris Packham
    0 references
    David Gray
    0 references
    April 2005
    0 references
    100
    0 references
    2
    0 references
    229-240
    0 references

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit